Stay updated with breaking news from Tempo Smart Button. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly and Company (NYSE: LLY) will begin rollout of its first connected platform, the Tempo® Personalized Diabetes Management Platform, later this year in the U.S. The technology aims to help adults living with type 1 or type 2 diabetes and clinicians make informed, data-backed decisions to manage treatment ...
Centralized experience supports diabetes self-management through medication reminders, education resources and insulin dose logging Data shared through...
Centralised experience supports diabetes self-management through medication reminders, education resources and insulin dose logging
Centralized experience supports diabetes self-management through medication reminders, education resources and insulin dose loggingData shared through platform interface may help healthcare...
Eli Lilly and Co (NYSE:NYSE:LLY) Q3 2022 Earnings Conference Call November 01, 2022, 09:00 ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat...